Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hirata

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Drugs|November 13, 2014
Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritisYoshiya Tanaka, Shintaro Hirata
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) scoreShintaro Hirata, Yoshiya Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2016
[New assessment method in rheumatoid arthritis]Shintaro Hirata, Yoshiya Tanaka
Expert Review of Clinical Pharmacology|November 26, 2014
Combination therapy for early rheumatoid arthritis: a treatment holiday perspectiveShintaro Hirata, Yoshiya Tanaka
Clinical Therapeutics|December 3, 2013
Is it possible to withdraw biologics from therapy in rheumatoid arthritis?Yoshiya Tanaka, Shintaro Hirata
Clinical Calcium|November 27, 2015
[Imaging assessment of bone and cartilage destruction in rheumatoid arthritis]Shintaro Hirata, Yoshiya Tanaka
Clinical and Experimental Rheumatology|October 17, 2013
Discontinuation of biologics in patients with rheumatoid arthritisYoshiya Tanaka, Shintaro Hirata, Benazir Saleem, et al.
Modern Rheumatology|June 21, 2023
Development of a nursing practice scale for rheumatoid arthritis treatment with biological disease-modifying anti-rheumatic drugsFang Song, Hisae Nakatani, Eiji Sugiyama, et al.
JMA Journal|February 12, 2026
Impact of the 2018 Japan Floods on Methotrexate and Antirheumatic Drug Prescriptions: A Longitudinal Analysis of the Japanese National DatabaseGenki Kidoguchi, Shuhei Yoshida, Tomohiro Sugimoto, et al.
Arthritis Research & Therapy|October 10, 2015
Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumabShintaro Hirata, Anthony Marotta, Yuan Gui, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Drugs|November 13, 2014
Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritisYoshiya Tanaka, Shintaro Hirata
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) scoreShintaro Hirata, Yoshiya Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 18, 2016
[New assessment method in rheumatoid arthritis]Shintaro Hirata, Yoshiya Tanaka
Expert Review of Clinical Pharmacology|November 26, 2014
Combination therapy for early rheumatoid arthritis: a treatment holiday perspectiveShintaro Hirata, Yoshiya Tanaka
Clinical Therapeutics|December 3, 2013
Is it possible to withdraw biologics from therapy in rheumatoid arthritis?Yoshiya Tanaka, Shintaro Hirata
Clinical Calcium|November 27, 2015
[Imaging assessment of bone and cartilage destruction in rheumatoid arthritis]Shintaro Hirata, Yoshiya Tanaka
Clinical and Experimental Rheumatology|October 17, 2013
Discontinuation of biologics in patients with rheumatoid arthritisYoshiya Tanaka, Shintaro Hirata, Benazir Saleem, et al.
Modern Rheumatology|June 21, 2023
Development of a nursing practice scale for rheumatoid arthritis treatment with biological disease-modifying anti-rheumatic drugsFang Song, Hisae Nakatani, Eiji Sugiyama, et al.
JMA Journal|February 12, 2026
Impact of the 2018 Japan Floods on Methotrexate and Antirheumatic Drug Prescriptions: A Longitudinal Analysis of the Japanese National DatabaseGenki Kidoguchi, Shuhei Yoshida, Tomohiro Sugimoto, et al.
Arthritis Research & Therapy|October 10, 2015
Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumabShintaro Hirata, Anthony Marotta, Yuan Gui, et al.
Pageof 16